In recent years, GSH has emerged as a promising therapeutic trigger and biomarker, driving the development of nanotechnology-enabled platforms for controlled drug release, imaging, and theranostics
Rai et al., 2014), with the most recent including data from 34 case-control studies for a total of 3.098 MDS and 4.852 control mothers (Rai et al., 2)
[PubMed] [Google Scholar] 22.Chan H.M., Satoh M., Zalups R.K., Cherian M.G
Endometriosis Malignant transformation: epigenetics as a probable mechanism in ovarian tumorigenesis
A 2025 case report documented severe fever, abrupt liver damage, and clotting problems associated with high-dose IV glutathione, which is uncontrolled
doi:10.1017/S1092852900002157